Federal Grand Jury Investigating Pharmaceutical Company Linked to Meningitis Outbreak

By Grant Law Office on December 19, 2012

Subpoenas are being issued to people who worked at the pharmaceutical company linked to the current meningitis outbreak that has killed 39 people nationwide. According to a news report in The Boston Globe, a federal grand jury has begun investigating the New England Compounding Center (NECC), a Framingham compounding pharmacy responsible for making the tainted steroid injections. The report states that federal prosecutors are considering criminal charges against the companies or people who were responsible for the outbreak.

According to the data collected by the U.S. Centers for Disease Control and Prevention (CDC), the current meningitis outbreak has resulted in 39 fatalities. The ongoing fungal infection has resulted in 620 cases across 37 states. Of the estimated 14,000 patients who may have received the tainted injections, nearly 97 percent have been contacted for further follow-up. According to the most recent statistics, only one person in Georgia has been diagnosed with meningitis. It is unclear how many more people may suffer symptoms because of the three recalled lots of preservative-free methylprednisolone acetate.

When a drug is defective, the resulting consequences can be severe. Victims of recalled medications may pursue financial compensation for their significant losses from the at-fault manufacturer. Surviving victims of dangerous drugs may seek support for their medical bills, suffering, lost wages, and other related damages. If you have lost a loved one as the result of a defective product, compensation may be sought for damages such as lost future income, medical expenses, and funeral costs.

Anyone who has been affected by this recent outbreak would be well advised to contact an experienced meningitis lawsuit lawyer at the Law Offices of Wayne Grant, P.C. We offer free consultations at (404) 995-3955 to anyone who has been affected by this fungal meningitis outbreak. Please contact us to find out how we can help you.